Regenerative Biologics for Medspas and Dermatology in Denver, CO

Vendor review in a medspa or dermatology setting

Medspas operating under physician supervision, along with dermatology and aesthetic surgery practices, generally route a new biologics vendor through whoever holds the medical director role, since that person signs off on what the practice offers under its supervising physician. That review typically starts with a request for the supplier's documentation rather than marketing material.

Because medspas are not themselves licensed tissue banks or manufacturers, the practice's medical director is usually the one confirming with counsel how a given product fits the practice's regulatory posture before it is stocked.

What documentation to request

Ask for the certificate of analysis, donor eligibility summary, and lot release record tied to the specific lot being purchased. For exosome products, also request the available characterization data and full ingredient disclosure, since formats like Bio EX and Bio AER include disclosed composition alongside the exosome preparation itself.

NPI-verified ordering and cold-chain receiving

Orders are limited to accounts verified against an NPI number, which is checked against the public NPI Registry before activation. Cryopreserved Wharton's jelly products arrive overnight on dry ice in validated containers and should move straight into -80 degree C storage; lyophilized exosome formats are shelf-stable and store at room temperature per the product insert.

Confirming your practice's regulatory standing

Precision Biologics does not provide medical or legal advice. Confirm with the Colorado medical board and your own counsel how your practice's supervising-physician structure applies to any product you add to inventory, and keep lot-level records on file in case that documentation is requested later.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.